Document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
Filed by the Registrant ☒
Filed by a party other than the Registrant ☐
Check the appropriate box:
Preliminary Proxy Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material under §240.14a-12
OCUGEN, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
No fee required
Fee paid previously with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11




The below filing relates to the 2023 Annual Meeting of Shareholders of Ocugen, Inc. (the “Company”).
The following communication was made available by the Company on Twitter and LinkedIn on June 21, 2023:

Votes for the 2023 Ocugen Annual Shareholder Meeting are still being recorded. For those shareholders who have yet to vote, we are in need of your engagement – please vote!

https://cdn.kscope.io/5616f177c5c3d45f2cc0124e26b32d27-castyourvoteimagea.jpg